NanoViricides NNVC Stock
NanoViricides Price Chart
NanoViricides NNVC Financial and Trading Overview
| NanoViricides stock price | 1.4 USD |
| Previous Close | 1.08 USD |
| Open | 1.13 USD |
| Bid | 1.05 USD x 800 |
| Ask | 1.53 USD x 1000 |
| Day's Range | 1.08 - 1.12 USD |
| 52 Week Range | 1.04 - 3.88 USD |
| Volume | 16.35K USD |
| Avg. Volume | 47.05K USD |
| Market Cap | 12.72M USD |
| Beta (5Y Monthly) | 1.10669 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.71 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.25 USD |
NNVC Valuation Measures
| Enterprise Value | 2.95M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.6029412 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6978233 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.467 |
Trading Information
NanoViricides Stock Price History
| Beta (5Y Monthly) | 1.10669 |
| 52-Week Change | -45.77% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.88 USD |
| 52 Week Low | 1.04 USD |
| 50-Day Moving Average | 1.22 USD |
| 200-Day Moving Average | 1.45 USD |
NNVC Share Statistics
| Avg. Volume (3 month) | 47.05K USD |
| Avg. Daily Volume (10-Days) | 30.45K USD |
| Shares Outstanding | 11.67M |
| Float | 11.16M |
| Short Ratio | 15.28 |
| % Held by Insiders | 4.38% |
| % Held by Institutions | 11.72% |
| Shares Short | 389.58K |
| Short % of Float | 3.52% |
| Short % of Shares Outstanding | 3.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.18% |
| Return on Equity (ttm) | -31.63% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -6313275 USD |
| Net Income Avi to Common (ttm) | -6798577 USD |
| Diluted EPS (ttm) | -0.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.65M USD |
| Total Cash Per Share (mrq) | 0.83 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 28.477 |
| Book Value Per Share (mrq) | 1.562 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5569171 USD |
| Levered Free Cash Flow (ttm) | -3400159 USD |
Profile of NanoViricides
| Country | United States |
| State | CT |
| City | Shelton |
| Address | 1 Controls Drive |
| ZIP | 06484 |
| Phone | 203 937 6137 |
| Website | https://www.nanoviricides.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 17 |
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut.
Q&A For NanoViricides Stock
What is a current NNVC stock price?
NanoViricides NNVC stock price today per share is 1.4 USD.
How to purchase NanoViricides stock?
You can buy NNVC shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NanoViricides?
The stock symbol or ticker of NanoViricides is NNVC.
Which industry does the NanoViricides company belong to?
The NanoViricides industry is Biotechnology.
How many shares does NanoViricides have in circulation?
The max supply of NanoViricides shares is 15.64M.
What is NanoViricides Price to Earnings Ratio (PE Ratio)?
NanoViricides PE Ratio is now.
What was NanoViricides earnings per share over the trailing 12 months (TTM)?
NanoViricides EPS is -0.71 USD over the trailing 12 months.
Which sector does the NanoViricides company belong to?
The NanoViricides sector is Healthcare.
NanoViricides NNVC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE AMEX COMPOSITE INDEX XAX | 4596.92 USD — |
+1.02
|
— — | 4550.54 USD — | 4643.08 USD — | — - | — — |
- {{ link.label }} {{link}}